Blueprint Medicines OverviewBlueprint Medicines EBIT
EBIT (Earnings Before Interest and Taxes) analysis for BPMC.
Quarterly EBIT
-$6.84M
↑ 91.32% YoY
As of Mar 31, 2025
Annual EBIT (TTM)
-$118.24M
↑ 73.57% YoY
Trailing 12 months ending Mar 31, 2025
Blueprint Medicines OverviewEBIT (Earnings Before Interest and Taxes) analysis for BPMC.
As of Mar 31, 2025
Trailing 12 months ending Mar 31, 2025